Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-02-06Clinical Trial Update: Effects of Tralokinumab in the Skin: an Immunologic and Molecular Investigation [Phase 2, Phase 3]
A Phase 2/3 trial evaluating tralokinumab for atopic dermatitis sponsored by the University of Zurich has been terminated.
-
CLINICAL_TRIALS withdrawal · 2025-11-28Clinical Trial Update: Study of Growth and Bone Mineral Density in Children With Atopic Dermatitis (AD) Treated With Dupilumab [Phase 4]
A Phase 4 clinical trial evaluating growth and bone mineral density in children with atopic dermatitis treated with dupilumab has been withd…
-
CLINICAL_TRIALS withdrawal · 2025-08-03Clinical Trial Update: A Study of Topical BX005-A in Subjects With Moderate to Severe Atopic Dermatitis [Phase 1, Phase 2]
A Phase 1/2 trial evaluating topical BX005-A for moderate to severe Atopic Dermatitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Pilot Study to Explore the Role of Gut Flora in Eczema
A pilot clinical trial investigating the role of gut microbiota in eczema has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-12-02Clinical Trial Update: Open-label Pilot Clinical Trial of Oral Ivermectin to Treat Atopic Dermatitis [Phase 2]
An open-label Phase 2 pilot trial evaluating oral ivermectin for atopic dermatitis was withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2024-11-07Clinical Trial Update: Investigation of Flare and Remission in Subjects With Atopic Dermatitis [Phase 4]
A Phase 4 clinical trial investigating flare and remission in subjects with atopic dermatitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-10-09Clinical Trial Update: An Investigation of a Multi-Function Skincare Product to Improve Aging, Eczema, and Acne Outcomes [NA]
A clinical trial evaluating a multi-function skincare product for acne and eczema (with considerations for skin aging) has been withdrawn; s…
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: A Study to Assess the Effect of Upadacitinib in Atopic Dermatitis-induced Sleep Disturbance in Adults With Moderate to Severe Atopic Dermatitis [Phase 3]
A Phase 3 trial evaluating Upadacitinib for Atopic Dermatitis–associated sleep disturbance has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-09-03Clinical Trial Update: Treatment of Nighttime Pruritus in Atopic Dermatitis [EARLY_Phase 1]
An early-phase clinical trial assessing treatment for nighttime pruritus in atopic dermatitis was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-08-09Clinical Trial Update: A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Repeated-dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis [Phase 1]
A Phase 1 study evaluating BxC-I17e for moderate to severe atopic dermatitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-09-21Clinical Trial Update: Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis With Inadequate Response to or for Whom Cyclosporine A is Not Medically Advisable [Phase 3]
Phase 3 clinical trial of nemolizumab in moderate-to-severe atopic dermatitis with inadequate response to cyclosporine A or for whom cyclosp…
-
CLINICAL_TRIALS withdrawal · 2023-03-21Clinical Trial Update: CBP-201 in Adolescent and Adult Patients With Moderate-to-severe Atopic Dermatitis [Phase 3]
Phase 3 trial of CBP-201 for moderate-to-severe atopic dermatitis was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2022-12-19Clinical Trial Update: Comparison of JW-100 and EUCRISA for the Treatment of Atopic Dermatitis [Phase 3]
Phase 3 trial comparing JW-100 and EUCRISA for atopic dermatitis was withdrawn.
-
EMA withdrawal · 2022-02-08EMA Withdrawn: Staquis (Crisaborole) — Pfizer Europe MA EEIG
The EMA has withdrawn Staquis (crisaborole) from the market in Europe.
-
CLINICAL_TRIALS withdrawal · 2021-04-08Clinical Trial Update: A Study of Oral Upadacitinib Tablets to Assess Change in Disease State in Participants Aged 12-75 Years With Moderate to Severe Atopic Dermatitis in Brazil [Phase 3]
Phase 3 trial of oral upadacitinib for moderate to severe atopic dermatitis in Brazil has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-01-17Clinical Trial Update: A Trial of a Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis [Phase 2]
A Phase 2 clinical trial evaluating a botanical product containing East Indian Sandalwood Oil for atopic dermatitis has been withdrawn. Spon…
-
CLINICAL_TRIALS withdrawal · 2018-07-06Clinical Trial Update: Pediatric Atopic Dermatitis (AD) Internet Survey [NA]
A pediatric internet survey trial in atopic dermatitis sponsored by Wake Forest University has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-06-12Clinical Trial Update: Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy [NA]
Clinical trial evaluating skin barrier dysfunction in infants at high risk of atopy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-05-15Clinical Trial Update: A Study of the Efficacy and Safety of Orvepitant in Subjects With Pruritus Associated With Atopic Dermatitis [Phase 2]
A Phase 2 study evaluating Orvepitant for pruritus associated with atopic dermatitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-03-24Clinical Trial Update: Study to Examine the Benefits of Fabric Made With Lyocell/Chitosan/Ceramide in the Treatment of Children With Mild to Moderate Eczema [NA]
A pediatric study evaluating fabric made with Lyocell/Chitosan/Ceramide for mild-to-moderate atopic dermatitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-12-01Clinical Trial Update: A Placebo Controlled 4 Week Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild Atopic Dermatitis (RO-2351-001-EM) [Phase 2]
Withdrawal notice for a Phase 2 placebo-controlled proof-of-concept study evaluating 0.5% roflumilast cream in mild atopic dermatitis.
-
CLINICAL_TRIALS withdrawal · 2016-09-16Clinical Trial Update: The Effects of Polyunsaturated Fatty Acids (PUFA) on Allergic/Atopic Dermatitis [NA]
The clinical trial evaluating polyunsaturated fatty acids for atopic dermatitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-09-09Clinical Trial Update: Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older [Phase 3]
The Phase 3 study of MSRD-100 in subjects with atopic dermatitis has been withdrawn. The sponsor is Merz North America, Inc.
-
CLINICAL_TRIALS withdrawal · 2016-09-09Clinical Trial Update: Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older [Phase 3]
A Phase 3 study evaluating MSRD-100 for atopic dermatitis was withdrawn, and the trial is no longer active.
-
CLINICAL_TRIALS withdrawal · 2016-03-16Clinical Trial Update: The Effects of Probiotics in Atopic Dermatitis [NA]
The UCLA-sponsored clinical trial investigating probiotics for atopic dermatitis has been withdrawn.